Furthermore, brain tumors (low-grade glioma, glioblastoma multiforme) and ovarian tumors (serous cystadenocarcinoma) also had lower APOBEC3B expression levels than breast carcinoma. This evidence concerns the gene APOBEC3B and brain neoplasm.